Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ausnutria Dairy Corporation Ltd (1717.HK)
Sheung Wan, HK
Ausnutria Dairy Corporation Ltd, an investment holding firm, is primarily involved in the entire lifecycle of infant formula and other dairy products, encompassing research and development, milk sourcing, processing, manufacturing, packaging, marketing, and distribution. Its operations are divided into two main divisions: Dairy and Related Products, and Nutrition Products. The company markets cow milk-based formula products under brand names such as Allnutria, Hyproca Hollary, Hyproca Hypure, Neolac, and Puredo. Additionally, its goat milk-based infant formula is sold under the Kabrita brand. Ausnutria also functions as an original equipment manufacturer (OEM) for formula milk powder products. Beyond dairy, it manufactures and distributes various nutrition products, develops and sells probiotic items, and offers financing solutions. Its global footprint spans the People's Republic of China, the European Union, Southeast Asia, Australia, New Zealand, the Middle East, North and South America, and other international markets. Established in 2003, Ausnutria Dairy Corporation Ltd is headquartered in Sheung Wan, Hong Kong, and operates as a subsidiary of HongKong Jingang Trade Holding Company Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.73% | +2.99% | -10.97% | -30.30% | -38.12% | -30.65% | -29.23% | -60.00% | -89.08% | -40.00% | -72.94% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+1.2% Q4'25: +38.3% (vs Q4'23)
-
EPS growth Packaged Foods: +14.6%-23.2% Q4'25: +943.9% (vs Q4'23)
-
FCF margin FCF growth · Packaged Foods: +15.9%+2.2% Q4'25: +0.2% (vs Q4'23)
-
EBIT margin Packaged Foods: +7.9%+2.1% Q4'25: +1.4% (vs Q4'23)
-
ROIC Packaged Foods: +7.0%+1.8% Q4'25: +3.9% (vs Q4'23)
-
Share dilution Packaged Foods: +0.0%-0.1% ★ Q4'25: -0.8% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×5.97× Q4'25: 1.89× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2009 actual |
Dec 2010 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
623.78M
est: 646.40M (-3.5%)
|
579.33M
est: 569.70M (+1.7%)
|
3.93B
est: 4.48B (-12.3%)
|
5.39B
est: 6.11B (-11.8%)
|
6.74B
est: 7.57B (-11.0%)
|
7.99B
est: 9.68B (-17.5%)
|
8.58B
est: 11.10B (-22.7%)
|
7.80B
est: 8.97B (-13.1%)
|
7.38B
est: 7.02B (+5.1%)
|
7.40B
est: 7.68B (-3.6%)
|
7.49B
est: 7.48B (+0.1%)
|
8.17B
8.09B – 8.31B
+9.2% YoY
|
8.61B
8.44B – 8.81B
+5.4% YoY
|
9.01B
8.88B – 9.20B
+4.7% YoY
|
| EBITDA |
175.03M
est: 72.13M (+142.7%)
|
125.71M
est: 163.49M (-23.1%)
|
538.18M
est: 917.21M (-41.3%)
|
975.56M
est: 570.38M (+71.0%)
|
1.32B
est: 1.02B (+29.2%)
|
1.50B
est: 1.30B (+14.7%)
|
1.26B
est: 1.54B (-17.8%)
|
529.51M
est: 1.93B (-72.5%)
|
503.39M
est: 603.06M (-16.5%)
|
645.26M
est: 661.98M (-2.5%)
|
439.20M
est: 642.33M (-31.6%)
|
701.14M
694.35M – 713.35M
+9.2% YoY
|
739.16M
724.65M – 756.39M
+5.4% YoY
|
773.71M
762.28M – 789.52M
+4.7% YoY
|
| EBIT |
172.71M
est: 50.43M (+242.5%)
|
68.20M
est: 161.63M (-57.8%)
|
461.69M
est: 906.76M (-49.1%)
|
822.27M
est: 543.92M (+51.2%)
|
1.14B
est: 899.94M (+26.7%)
|
1.25B
est: 1.18B (+6.4%)
|
986.44M
est: 1.39B (-28.8%)
|
273.03M
est: 1.74B (-84.3%)
|
252.72M
est: 357.63M (-29.3%)
|
364.16M
est: 392.57M (-7.2%)
|
157.88M
est: 380.91M (-58.6%)
|
415.79M
411.76M – 423.03M
+9.2% YoY
|
438.33M
429.73M – 448.55M
+5.4% YoY
|
458.82M
452.05M – 468.20M
+4.7% YoY
|
| Net Income |
182.12M
est: 299.17M (-39.1%)
|
110.17M
est: 141.23M (-22.0%)
|
308.13M
est: 792.33M (-61.1%)
|
635.10M
est: 370.76M (+71.3%)
|
878.39M
est: 706.47M (+24.3%)
|
1.00B
est: 910.48M (+10.3%)
|
763.79M
est: 1.07B (-28.8%)
|
216.53M
est: 195.42M (+10.8%)
|
174.39M
est: 125.74M (+38.7%)
|
235.98M
est: 247.24M (-4.6%)
|
177.51M
est: 219.40M (-19.1%)
|
255.16M
245.71M – 264.60M
+16.3% YoY
|
290.11M
283.50M – 296.73M
+13.7% YoY
|
316.79M
307.73M – 325.85M
+9.2% YoY
|
| SGA |
102.51M
est: 223.52M (-54.1%)
|
196.03M
est: 79.42M (+146.8%)
|
1.27B
est: 445.55M (+184.4%)
|
1.91B
est: 1.52B (+25.0%)
|
2.33B
est: 2.12B (+9.9%)
|
2.76B
est: 2.42B (+14.3%)
|
2.93B
est: 2.85B (+3.0%)
|
2.77B
est: 3.57B (-22.3%)
|
2.44B
est: 2.43B (+0.7%)
|
2.63B
est: 4.15B (-36.6%)
|
2.57B
est: 2.58B (-0.4%)
|
2.82B
2.79B – 2.87B
+9.2% YoY
|
2.97B
2.92B – 3.04B
+5.4% YoY
|
3.11B
3.07B – 3.18B
+4.7% YoY
|
| EPS |
0.17
est: 0.17 (+1.1%)
|
0.06
est: 0.13 (-54.9%)
|
0.25
est: 0.27 (-7.4%)
|
0.47
est: 0.45 (+4.7%)
|
0.55
est: 0.63 (-13.0%)
|
0.61
est: 0.75 (-19.1%)
|
0.44
est: 0.85 (-48.1%)
|
0.12
est: 0.33 (-63.1%)
|
0.10
est: 0.07 (+37.9%)
|
0.13
est: 0.15 (-16.1%)
|
0.10
est: 0.13 (-23.2%)
|
0.15
0.14 – 0.15
+11.7% YoY
|
0.16
0.16 – 0.17
+11.9% YoY
|
0.18
0.17 – 0.18
+10.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-28 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-27 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-21 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Zhijian Ren | Chief Executive Officer & Executive Director | 4M | male |
| Bartle van der Meer | Executive Director | 2M | male |
| Zhi Zhang | Chief Supply Chain Officer & Executive Director | 2M | male |
| Ruijie Yang | Chief Financial Officer | — | female |
| Tracy Sun | Head of Investor Relations | — | female |
| Wei Li | Chief Research & Development Officer | — | male |
| Xueqin Zhang | Vice President & Financial Controller | — | female |
| Ka Lai Cheung | Company Secretary | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1717.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
